News Releases

Investor Alerts

Jan 2, 2019

IDEAYA Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019
Dec 4, 2018

IDEAYA Biosciences, Inc. appoints Bao Truong as Vice President, Head of Regulatory Affairs
Oct 23, 2018

IDEAYA Licenses Phase 1 Compound LXS196 For The Treatment Of Cancers With GNAQ And GNA11 Mutations
Jun 6, 2018

IDEAYA Biosciences to Present at the 2018 Jefferies Global Healthcare Conference
Jun 5, 2018

IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D. as Vice President, Head of Biomarkers and Synthetic Lethal Biology
Mar 15, 2018

IDEAYA Biosciences Raises $94 Million Crossover Series B Financing

Co-led by Nextech Invest, 6 Dimensions Capital, BVF Partners, and Perceptive Advisors
Mar 13, 2018

IDEAYA Biosciences Appoints Julie Hambleton, M.D., as Senior Vice President and Chief Medical Officer, Head of Development
Mar 13, 2018

IDEAYA Biosciences and Cancer Research UK Announce Partnership Agreement to Develop Small Molecule Inhibitors of PARG

Data related to PARG program to be presented at American Association of Cancer Research (AACR) Annual Meeting
Jan 5, 2018

IDEAYA Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
Sep 6, 2017

IDEAYA Biosciences to Participate in Emerging Innovators Panel at Citi’s 12th Annual Biotech Conference

Show per page